Climb Biotherapeutics, Inc. CLYM
$11.17
▲ +4.86% 24H
About
Climb Biotherapeutics, Inc. is a company in the biotechnology industry, focusing on the development and commercialization of novel therapeutic solutions. Primarily, it plays a role in advancing treatments for conditions that lack efficient medical solutions, positioning itself at the forefront of innovation in health c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees28
TickerCLYM
Statistics
Market Cap$533.6M
Revenue (TTM)$0
Net Income-$59.9M
Net Margin—
EPS$-0.88
P/E-13.00
P/S—
P/B3.69
EV/EBITDA-6.48
ROE-30.9%
Dividend Yield—
Price$11.17
Data: Twelve Data · Revenue = mcap / P/S